Linagliptin 2.5 mg "

Aug 16, 2023

Linagliptin 2.5 mg
LINALIGLIP is a medication that belongs to a class of drugs known as dipeptidyl peptidase-4 (DPP-4) inhibitors. LINALIGLIP is primarily used in the management of type 2 diabetes mellitus. LINALIGLIP works by inhibiting the DPP-4 enzyme, which is responsible for breaking down incretin hormones such as glucagon-like peptide-1 (GLP-1). GLP-1 helps regulate blood sugar levels by increasing insulin release from the pancreas and reducing the production of glucagon, a hormone that raises blood sugar.
By inhibiting DPP-4, LINALIGLIP prolongs the activity of GLP-1 and enhances its effects, leading to better blood sugar control. LINALIGLIP helps lower both fasting and postprandial (after-meal) blood sugar levels.
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now:
https://www.sterisonline.com/product/linaliglip-2-5-134280

SHARE WITH